Kyowa Hakko Bio

[{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Moffitt Cancer Center","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2024","type":"Inapplicable","leadProduct":"Mogamulizumab","moa":"C-C chemokine receptor type 4","graph1":"Oncology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Amino Acid","year":"2020","type":"Inapplicable","leadProduct":"Citrulline","moa":"G-protein coupled receptor GPCR33 (GPRC6A)","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"JAPAN","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"HMO","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Undisclosed"}]